Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136887 · ClinicalTrials.gov registry record
JOURNEY II XR Safety and Effectiveness PMCF
A clinical trial of Knee Osteoarthritis and Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, sponsored by Smith & Nephew.
- Active
- Registry status
- 176
- Enrollment target
- 14
- Study locations
NCT03136887: Active study of Knee Osteoarthritis and Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, sponsored by Smith & Nephew.
NCT03136887 is a study of Knee Osteoarthritis and Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee that is active but no longer recruiting, run by Smith & Nephew. The registered enrollment target is 176 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03136887, a study of Knee Osteoarthritis and Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, is active but no longer recruiting, sponsored by Smith & Nephew.
- ACTIVE NOT RECRUITING
- Registry status
- 176 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study was designed to demonstrate the safety and performance of the JOURNEY II XR total knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All participants will be implanted with the JOURNEY II XR total knee system.
Primary Outcome
Did knee survive with no revision through 10 years
Conditions Studied
Interventions
- DEVICE JOURNEY II XR Total Knee System
Study Locations (14)
New York
- NYU Hospital for Joint Diseases / NYU Langone Medical Center - New York
- Hospital for Special Surgery - New York
- Columbia University Center for Hip & Knee Replacement - New York
Illinois
- Castle Orthopaedics & Sports Medicine, S.C. - Aurora
- Midwest Orthopaedics at Rush - Chicago
California
- Loma Linda University Dept. of Orthopaedic Surgery - Loma Linda
Florida
- Holy Cross Orthopedic Institute - Fort Lauderdale
Maryland
- Anne Arundel Medical Center - Annapolis
Michigan
- DeClaire LaMacchia Orthopaedic Institute - Rochester
Nevada
- Reno Orthopaedic Center - Reno
New Jersey
- Mercer Bucks Orthopaedics - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2017-07-28 |
| Est. Completion | 2029-04 |
What the registry record for NCT03136887 still lists
NCT03136887 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower).
The record links to 6 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which JOURNEY II XR Total Knee System is the first listed.
NCT03136887 lists 14 locations in 11 states (New York, Illinois, California).
Frequently Asked Questions
What is clinical trial NCT03136887 about?
NCT03136887 is a clinical study titled "JOURNEY II XR Safety and Effectiveness PMCF". This study was designed to demonstrate the safety and performance of the JOURNEY II XR total knee system by evaluating implant survival rates at 10 years using Kaplan-Meier analysis. All participants will be implanted with the JOURNEY II XR total knee system.
What is the current status of trial NCT03136887?
This trial is currently active not recruiting. The enrollment target is 176 participants. The study started on 2017-07-28. Estimated completion is 2029-04.
What conditions does trial NCT03136887 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, Unilateral Post-Traumatic Osteoarthritis of Knee, Degenerative Arthritis Peripheral Joint, Failed Osteotomies.
What interventions are being tested in trial NCT03136887?
The interventions under investigation include: JOURNEY II XR Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03136887?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136887 being conducted?
This trial has 14 study locations across California, Florida, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03136887's enrollment target sits among peer trials
176 27th of 101 higher than 74 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
RECRUITING · Early Phase 1
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis
RECRUITING
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI